DNA sequences downstream from the vitamin D response element of the rat osteocalcin gene are required for ligand-dependent transactivation.

The sequences in the rat osteocalcin gene that lie 3' to the vitamin D response element (VDRE) have been shown to augment transcriptional activation by 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3]. These DNA sequences, however, are unable to bind the VDR or mediate 1,25-(OH)2D3 responsiveness independently of the VDRE. To further characterize this region, the functional properties of a series of mutant oligonucleotides were examined in transiently transfected ROS 17/2.8 cells. When these mutant oligonucleotides were expressed upstream of the heterologous herpes simplex virus thymidine kinase promoter, the bases between -420 and -414 of the rat osteocalcin gene were identified as critical for maximal transactivation by 1,25-(OH)2D3. Furthermore, mutation of these sequences in the context of the native osteocalcin promoter and enhancer totally abolished the ability of the VDRE to mediate 1,25-(OH)2D3 responsiveness. These bases, which are essential for the 1,25-(OH)2D3 responsiveness of the rat osteocalcin gene, are also present in a similar position, relative to the VDRE, in the human osteocalcin gene. To explore whether these sequences could enhance transactivation by other inducible transcription factors, they were examined for their ability to synergize with the chick vitellogenin estrogen response element and the rat somatostatin cAMP response element. When placed upstream to the herpes simplex virus thymidine kinase promoter and transfected into ROS 17/2.8 cells, these sequences were able to enhance transcriptional responsiveness to 17beta-estradiol and forskolin, respectively, demonstrating that they also contribute to transactivation by other inducible transcription factors.

[1]  L. Guarente,et al.  Transcriptional coactivators in yeast and beyond. , 1995, Trends in biochemical sciences.

[2]  B. O’Malley,et al.  Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily , 1995, Science.

[3]  Myles Brown,et al.  Polarity-specific activities of retinoic acid receptors determined by a co-repressor , 1995, Nature.

[4]  M. Haussler,et al.  A highly conserved region in the hormone-binding domain of the human vitamin D receptor contains residues vital for heterodimerization with retinoid X receptor and for transcriptional activation. , 1995, Molecular endocrinology.

[5]  P. Kushner,et al.  Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. , 1995, The EMBO journal.

[6]  H. DeLuca,et al.  Cloning of the human 1 alpha,25-dihydroxyvitamin D-3 24-hydroxylase gene promoter and identification of two vitamin D-responsive elements. , 1995, Biochimica et biophysica acta.

[7]  C. Suen,et al.  A potential transcriptional adaptor(s) may be required in thyroid hormone-stimulated gene transcription in vitro. , 1995, Endocrinology.

[8]  P. Chambon,et al.  The N‐terminal part of TIF1, a putative mediator of the ligand‐dependent activation function (AF‐2) of nuclear receptors, is fused to B‐raf in the oncogenic protein T18. , 1995, The EMBO journal.

[9]  G. Karsenty,et al.  Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene , 1995, Molecular and cellular biology.

[10]  D. Sherman,et al.  The Vitamin D Receptor Interacts with General Transcription Factor IIB (*) , 1995, The Journal of Biological Chemistry.

[11]  D. Moore,et al.  Interaction of thyroid-hormone receptor with a conserved transcriptional mediator , 1995, Nature.

[12]  L. Freedman,et al.  Transcriptional synergism between the vitamin D3 receptor and other nonreceptor transcription factors. , 1994, Molecular endocrinology.

[13]  M. Parker,et al.  Interaction of proteins with transcriptionally active estrogen receptors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[14]  G. Martin,et al.  Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. , 1994, Science.

[15]  S. Teitelbaum,et al.  Cloning of the promoter for the avian integrin beta 3 subunit gene and its regulation by 1,25-dihydroxyvitamin D3. , 1993, The Journal of biological chemistry.

[16]  S. Christakos,et al.  Identification of sequence elements in mouse calbindin-D28k gene that confer 1,25-dihydroxyvitamin D3- and butyrate-inducible responses. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[17]  H. DeLuca,et al.  Sequences in the human parathyroid hormone gene that bind the 1,25-dihydroxyvitamin D3 receptor and mediate transcriptional repression in response to 1,25-dihydroxyvitamin D3. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[18]  H. DeLuca,et al.  Characterization of 1,25-dihydroxyvitamin D3 receptor interactions with target sequences in the rat osteocalcin gene. , 1992, Molecular endocrinology.

[19]  K. Umesono,et al.  Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling , 1992, Nature.

[20]  C. Glass,et al.  RXRβ: A coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements , 1991, Cell.

[21]  Julian R. E. Davis,et al.  Multihormonal regulation of the human prolactin gene expression from 5000 bp of its upstream sequence , 1991, Molecular and Cellular Endocrinology.

[22]  G. Molloy,et al.  Identification of cis-acting regulatory elements in the promoter region of the rat brain creatine kinase gene , 1990, Molecular and cellular biology.

[23]  H. DeLuca,et al.  Identification of a DNA sequence responsible for binding of the 1,25-dihydroxyvitamin D3 receptor and 1,25-dihydroxyvitamin D3 enhancement of mouse secreted phosphoprotein 1 (SPP-1 or osteopontin) gene expression. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[24]  H. DeLuca,et al.  DNA sequences in the rat osteocalcin gene that bind the 1,25-dihydroxyvitamin D3 receptor and confer responsiveness to 1,25-dihydroxyvitamin D3. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. Shine,et al.  1,25-dihydroxyvitamin D-responsive element and glucocorticoid repression in the osteocalcin gene. , 1989, Science.

[26]  M. Beato.  Gene regulation by steroid hormones , 1989, Cell.

[27]  H. Kronenberg,et al.  Regions of the rat osteocalcin gene which mediate the effect of 1,25-dihydroxyvitamin D3 on gene transcription. , 1989, The Journal of biological chemistry.

[28]  W. Chin,et al.  An upstream region of the rat luteinizing hormone beta gene binds estrogen receptor and confers estrogen responsiveness. , 1989, The Journal of biological chemistry.

[29]  R. Maurer,et al.  Identification of an estrogen-responsive element from the 5'-flanking region of the rat prolactin gene , 1987, Molecular and cellular biology.

[30]  M. Montminy,et al.  Identification of a cyclic-AMP-responsive element within the rat somatostatin gene. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[31]  D. Moore,et al.  CAT vectors for analysis of eukaryotic promoters and enhancers. , 1986, Gene.

[32]  M. Brown-Luedi,et al.  Sequence homologies in the region preceding the transcription initiation site of the liver estrogen-responsive vitellogenin and apo-VLDLII genes. , 1984, Nucleic acids research.

[33]  J. Burch.  Identification and sequence analysis of the 5' end of the major chicken vitellogenin gene. , 1984, Nucleic acids research.

[34]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.